The Toronto Alexithymia Scale (TAS-26) was administered to patients with sexual disorders (n = 112) and to healthy control subjects (n = 94). The clinic sample was divided into three subgroups according to DSM-III-R criteria: patients with hypoactive sexual desire disorder (n = 41), patients with orgasm disorders (n = 51) and patients with male erectile disorder (n = 20). TAS scores were significantly higher for male and female patients with hypoactive sexual desire disorder, and with male erectile disorder than controls. The TAS scores in the orgasm disorder patients were not significantly different from those of controls. These results are interesting because they show an association betweeen alexithymia and some sexual symptoms.
© 2001 S. Karger AG, Basel
Franca Madioni, MD, PhD
Department of Psychiatry, University of Geneva
51 Bd de la Cluse
CH–1205 Genève (Switzerland)
Tel. +41 22 382 48 70, Fax +41 22 382 48 99, E-Mail Franca.Madioni@hcuge.ch
Number of Print Pages : 4
Number of Figures : 0, Number of Tables : 3, Number of References : 21
Psychopathology (International Journal of Descriptive Psychopathology Phenomenology and Clinical Diagnositcs)
Founded 1897 as ‘Monatsschrift für Psychiatrie und Neurologie’
Vol. 34, No. 2, Year 2001 (Cover Date: March-April 2001)
Journal Editor: E. Gabriel, Vienna; C. Mundt, Heidelberg
ISSN: 0254–4962 (print), 1423–033X (Online)
For additional information: http://www.karger.com/journals/psp
Article / Publication Details
Published online: 3/2/2001
Issue release date: March–April 2001
Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 3
ISSN: 0254-4962 (Print)
eISSN: 1423-033X (Online)
For additional information: http://www.karger.com/PSP
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.